Resveratrol treatment was found to reduce the expression of inflammatory factors NF‐κB, p65, receptor for advanced glycation end products (RAGE), and NADPH oxidase 4 (NOX4) in a mouse diabetic nephropathy model (Xian et al., 2020), suggesting its potential role in mitigating chronic inflammation. The gene discussed is NOX4; the disease is diabetic kidney disease.